Biofrontera Inc. (BFRI): auditor change — Biofrontera engages CBIZ CPAs as new auditor after Marcum's resignation tied to acquisition

Biofrontera Inc.

Marcum LLP resigned as auditor on April 17, 2025 after CBIZ CPAs acquired its attest business.
Biofrontera's audit committee approved engaging CBIZ CPAs as independent auditor for fiscal 2025.
Marcum's audit reports for 2024 and 2023 had no adverse opinion but included a going concern explanatory paragraph.
No reportable disagreements or events occurred with Marcum during the fiscal years 2024 and 2023.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marcum LLP resigned as auditor of Biofrontera Inc..

Action: resignation
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

On April 17, 2025, Marcum resigned as the independent registered public accounting firm of Biofrontera Inc. (the “Company”) and, with the approval of the Audit Committee of the Company’s Board of Directors, CBIZ CPAs was engaged as the Company’s independent registered public accounting firm for the year ending December 31, 2025.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Biofrontera Inc. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

On April 17, 2025, Marcum resigned as the independent registered public accounting firm of Biofrontera Inc. (the “Company”) and, with the approval of the Audit Committee of the Company’s Board of Directors, CBIZ CPAs was engaged as the Company’s independent registered public accounting firm for the year ending December 31, 2025.

View on SEC.gov

Browse all auditor changes →

Biofrontera Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-005428

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.